Muhammad Barkaat Hussain

Muhammad Barkaat Hussain

Auto-generated profile, based on publicly available information

Muhammad Barkaat Hussain

Department of Microbiology, Faculty of Medicine in Rabigh, King Abdulaziz University (KAU)

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2025 in Annals of Medicine
Verified
Journal Article
Open access
MHMuhammad Barkaat Hussain
Muhammad Barkaat Hussain
AAAbdullah Albukhari
Abdullah Albukhari
MRMisbahuddin M Rafeeq
Misbahuddin M Rafeeq
MIMuhammad Imran
Muhammad Imran
AAAli Hassan Albagholi
Ali Hassan Albagholi
MAMohammed Abdulsalam Assedoodi
Mohammed Abdulsalam Assedoodi
Dietary fiber has emerged as a preventive and adjuvant therapy for patients with colorectal carcinoma (CRC) because it possesses chemoprotective and direct anticancer properties, including the ability to modulate multiple cellular and molecular targets implicated in tumor cell survival, proliferation, invasion, angiogenesis, and immunomodulation. This review summarizes the latest epidemiological, preclinical, and clinical research on dietary fiber as a preventive and adjuvant therapy for CRC patients, focusing on the cellular and molecular mechanisms of the bioactive compounds present in or produced by fiber metabolism. A structured literature search was conducted in PubMed using a Boolean search strategy to identify relevant studies on the association between dietary fiber and CRC. Studies unrelated to dietary fiber or CRC, non-peer-reviewed materials, and articles with insufficient methodological details were excluded to maintain the focus and quality of the review. An overall body of epidemiological evidence suggests that the consumption of foods rich in dietary fiber or whole grains is associated with a reduced risk of CRC. Preclinical studies conducted in vitro and in animal models strongly support the hypothesis that dietary fiber is effective in preventing and treating CRC and provide mechanistic insights, indicating that diverse types of fiber, such as β-glucan, resistant starch, pectin, and arabinoxylan, have distinct but complementary effects. However, the findings of the clinical trials are inconclusive. This disconnect may stem from the differences in methodologies, fiber types, dosages, intervention durations, and endpoints across studies. According to the current evidence, dietary fiber appears to have a protective effect against the development of CRC. However, more targeted and prospectively planned RCTs using standardized dosages, formulations and combinations of dietary fiber are needed to provide additional evidence in favor of the recommendation of a high-fiber diet for the prevention and adjuvant treatment of CRC.

1 June 2021 in European Urology
Verified
Journal Article
Closed access
DSDenosshan Sri
Denosshan Sri
SSS. Sarkar
S. Sarkar
JOJ. Oakley
J. Oakley
MMM. Malki
M. Malki
MHM. Hussain
M. Hussain
NBN. Barber
N. Barber

16 March 2022 in Clinical Radiology
Verified
Journal Article
Closed access
PDF file
MMM. Mashar
M. Mashar
ASA. Said
A. Said
MHM. Hussain
M. Hussain
VEV. Eze
V. Eze